| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.18B | $12.12B | $12.16B |
| YoY Revenue Growth % | +0.5% | -0.3% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $4.36B | $4.07B | $2.85B |
| Operating Margin % | 35.8% | 33.6% | 23.5% |
| Net Income (GAAP) | $2.87B | $2.62B | $1.83B |
| EBITDA (Normalized) | $6.12B | $5.98B | $3.29B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.36B | $4.05B | $3.18B |
| Capital Expenditures (CapEx) | $2.20B | $2.38B | $547.0M |
| Free Cash Flow (FCF) | $2.16B | $1.67B | $2.63B |
| FCF Margin % | 17.7% | 13.8% | 21.7% |
| Return on Invested Capital (ROIC %) | 12.6% | 12.4% | 8.8% |
| Cash & Short-Term Equivalents | $1.53B | $1.64B | — |
| Total Debt (Short + Long Term) | $13.36B | $13.22B | $9.89B |
| Total Stockholders' Equity | $15.55B | $14.31B | $20.29B |